Structured JSON API for this factor page: https://sharemaestro.com/factors/api/tickers/2c4d5735-d3e4-4d6a-ba08-9a816aec67f1/

APTX

Apotex Health Corp.
Chart
38.00 CAD
Latest Week 2026-07-10
HealthcareDrug Manufacturers - Specialty & GenericMID
Snapshot 2026-07-12 · 0.9w · Fresh
0.81
OS Score
66.0%
Value
88.0%
Quality
38.0%
Momentum
8/9
F-Score
0.762
QV
StrategiesValueQualityMomentumCompositeInteractionsFactor AnalysisTrendsFundamentals
Strategy Eligibility
4 of 23 passing
★
OS Composite
OS 0.810
↗
Trending Value
✗
◆
Quality × Value
QV 0.762
🏛
Cornerstone Value
✗
🌿
Cornerstone Growth
✗
💎
Deep Value
✗
◇
VC2 Cheapest
✗
📐
EBITDA/EV
✗
◐
Veiled Value
✗
▣
Piotroski Bargains
F8
🔬
Quality Compounders
✗
📈
Consistent Earners
✗
🌱
GARP
✗
🔄
Shareholder Yield
14.2%
💰
High Yield
✗
🚀
Momentum Leaders
✗
◉
Market Leaders
✗
◎
Tiny Titans
✗
🔍
Small Cap Value
✗
🛡
Low Volatility
✗
🏷
Sector Cheapest
✗
🧠
Capital Allocators
✗
⚡
Risk-Adj Momentum
✗
V
Value Analysis
Cheapness relative to fundamentals
66.0%ile
P/E
23.6×
P/S
2.5×
E/P
0.0847
FCF Yield
0.037
EBITDA/EV
0.074
SH Yield
0.142
Relative Strength Across Value Dimensions
Multiples & Yields — Decomposition
VC1 (5-Factor)
71.00000000
/100 — 1=cheapest
VC2 (Trending Value)
33.00000000
/100
VC3 (Buyback)
36.00000000
/100
Q
Quality Analysis
Profitability, efficiency, balance sheet & earnings quality
88.0%ile
ROE
-0.670
ROA
0.082
Net Margin
0.107
Op Margin
0.298
GPA
0.427
Current
1.50
F-Score
8/9
Quality Radar — Relative Strength
Profitability & Leverage Breakdown
Rev Growth
0.042
Earn Growth
1.464
Accruals
-0.059
lower=better
5yr Consist
No
F-Score of 8/9 indicates strong fundamental improvement across multiple dimensions.
M
Momentum & Risk
Price trend, volatility regime, risk-adjusted returns
38.0%ile
Max DD 12M
0.0%
Return Comparison — 6M / 12M / 12-1
Volatility Regime — 60d vs 252d
OS
Composite & Factor Heatmap
All factors at a glance
0.81
Pillar Balance — Value / Quality / Momentum
Factor Heatmap — green=strong, red=weak
▦
Sector Context
Healthcare · 45 peers
Sector Value %ile
73.9%
Sector Quality %ile
95.7%
P/E z-score
-0.19
Sector Avg OS
44.8%
Ticker vs Sector Averages
Relative Valuation Z-Score
Top Sector Peers (By OS)
SymbolNameOSValueQualityMomentum
XLY Auxly Cannabis Group Inc. 93.0% 95.0% 85.0% 37.0%
DR Medical Facilities Corporation 91.0% 90.0% 91.0% 31.0%
TSND TerrAscend Corp. 89.0% 75.0% 63.0% 79.0%
BHC Bausch Health Companies Inc. 85.0% 87.0% 96.0% 7.0%
LOVE Cannara Biotech Inc. 85.0% 88.0% 82.0% 20.0%
CRRX CareRx Corporation 79.0% 78.0% 69.0% 30.0%
TLRY Tilray Brands, Inc. 79.0% 75.0% 6.0% 99.0%
CRDL Cardiol Therapeutics Inc. 76.0% 60.0% 62.0% 63.0%
Factor Interactions
Piotroski + Value Convergence
F-Score 8/9 with good value (66th). Strong fundamental improvement in a cheap stock.
⚖
Factor Analysis
Comprehensive factor intelligence — strengths, weaknesses & cross-factor profile
Value
B
63.1% avg (6 factors)
Quality
C
57.4% avg (7 factors)
▲ Top Strengths — highest scoring factors
▼ Key Weaknesses — lowest scoring factors
Score Trends5 snapshots
Factor Persistence5 snapshots
FactorCurrentStreakTrendSpark
OS Composite0.810—5—
Value %ile0.660—0—
Quality %ile0.880—5—
Momentum %ile0.380—0—
F-Score8.000—5—
Confidence0.683—0—
Volatility——0—
Value Lens2021-07-13 → 2026-07-12
P/E Ratio
Earnings Yield
Value FactorsCheapness relative to fundamentals — lower multiples = cheaper
P/E Ratio
23.56
Earnings Yield (E/P)
0.0847
Price / Sales
2.52
Price / Cash Flow
13.74
FCF Yield
3.7%
EBITDA / EV
7.4%
Sales Yield (1/P·S)
0.2845
Shareholder Yield
Div + net buyback / mktcap
14.2%
Quality FactorsProfitability, efficiency, and balance sheet strength
Return on Equity
-67.0%
Return on Assets
8.2%
Net Margin
10.7%
Operating Margin
29.8%
Gross Profit / Assets
Novy-Marx GPA
42.7%
Current Ratio
1.50
Accruals Ratio
(NI-OCF)/Assets — lower=better
-0.059
MomentumPrice trend strength over different horizons
Growth & StabilityEarnings trajectory, consistency, and capital allocation
Revenue Growth (YoY)
4.2%
Earnings Growth (YoY)
146.4%
5yr Consistent
EPS up every year for 5 years
No
Piotroski F-Score
8
Dividend Yield
12.6%
Buyback Yield
1.6%
O'Shaughnessy CompositesValue Composites (WWOWS 4th Ed) — 1=cheapest, 100=most expensive
VC1 (5-factor)
P/E+P/S+P/B+P/CF+EBITDA/EV
71
VC2 (6-factor)
VC1 + Shareholder Yield — used for Trending Value
33
VC3 (6-factor)
VC1 + Buyback Yield — no dividend preference
36
Capital Allocation & AlphaAlpha within factors — quality of management decisions
Veiled Value
Expensive by P/B, cheap by everything else
No
Market Leader
Above-avg mcap+revenue, non-utility
No
All Stocks Universe
Market cap > $200M
Yes
Tiny Titan
Micro-cap, low P/S, positive momentum
No
Annual Fundamentals
Revenue
Net Income
FCF
Net Margin
Show all
Op Income
OCF
CapEx
Equity